OCI publishes NNS declaration that offer is unconditional

Key highlights
  • NNS declared its offer unconditional after receiving tenders for 21,023,870 shares, worth EUR 86.2 million.
  • NNS and Nassef Sawiris will hold 67.45% of OCI after settlement.
  • Accepted shareholders are due EUR 4.10 per share, with settlement scheduled for 20 November 2026.
  • The post-closing acceptance period runs from 18 to 24 November 2026; shares tendered cannot be withdrawn.

Offer results

During the offer period, which ended on 17 November 2026, 21,023,870 shares were tendered, representing approximately 9.95% of OCI’s shares and an aggregate value of EUR 86,197,867. NNS declared the offer unconditional after all conditions were satisfied. Following settlement, NNS and Nassef Sawiris will hold 142,559,578 shares, or approximately 67.45% of the total. A further 19,167,618 shares, or approximately 9.07%, were not tendered.

Settlement and post-closing acceptance

Shareholders who accepted the offer will receive EUR 4.10 per tendered and delivered share, without interest. Settlement is scheduled for 20 November 2026, although NNS cannot guarantee payment on that date.

Shareholders may tender on the same terms during the post-closing acceptance period, from 18 November at 09:00 CET until 24 November 2026 at 17:40 CET. Results will be published no later than the third business day after the period ends. Shares tendered during this period cannot be withdrawn, and payment is due no later than the fourth business day after its close.

Potential post-closing measures

Statutory buy-out proceedings or post-closing restructuring measures are expected to be considered only if Rembrandt II cannot be implemented. Shareholders who do not tender are advised to review Sections 5.9 and 5.10 of the offer memorandum for the implications of remaining OCI shareholders.

Source: OCI

chemXplore Weekly

The week’s project milestones and project news from the chemical industry, free every Wednesday.

Free. One email a week. Unsubscribe any time. See our Privacy Policy.

Related articles

28 September 2026
OCI Global H1 2026 results and strategic progress

Net profit USD 1m; sold ammonia distribution and monetized Methanex; OCI Nitrogen impaired and facing margin pressure; held‑for‑sale net cash USD 1.05bn; NNS offer and Orascom deal progressing.

1 July 2026
OCI recommends NNS EUR 4.10 all-cash offer; court-appointed directors consent to convene EGM for Orascom vote

Board (excluding Nassef and Nadia Sawiris) backs NNS cash offer and court-appointed directors agree to convene an EGM to approve the Orascom transaction, conditional on NNS declaring and settling the offer.

25 June 2026
OCI court-appointed independent non-exec directors continue review of NNS cash offer

They stress independence under an Enterprise Court mandate, aim to finalise assessment by end-June 2026, and have not authorised an EGM to approve the proposed transaction.

24 June 2026
OCI confirms NNS intends EUR 4.10 per‑share voluntary cash offer

NNS plans a voluntary all‑cash offer at EUR 4.10 cum dividend per share; OCI board (excluding court‑appointed members) backs a cash option tied to the Orascom combination.